Tolerance to SARS-CoV-2 mRNA Vaccination in a Patient With Challenge-Confirmed PEG 2000 Allergy

J Investig Allergol Clin Immunol. 2023 Apr 18;33(2):149-150. doi: 10.18176/jiaci.0829. Epub 2022 May 31.

Authors

V Faihs¹, R Bent¹, U Darsow¹, T Biedermann¹, K Brockow¹

Affiliation

¹ Department of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany.

PMID: 35638391
DOI: 10.18176/jiaci.0829

No abstract available

Keywords: Anaphylaxis; Polyethylene glycol; SARS-CoV-2. COVID-19; mRNA vaccine.

MeSH terms

Anaphylaxis*
COVID-19* / prevention & control
Humans
Hypersensitivity*
Polyethylene Glycols
RNA, Messenger
SARS-CoV-2
Vaccination / adverse effects

Substances

polyethylene glycol 2000
RNA, Messenger
Polyethylene Glycols